Viewing nowArovant 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

MFDS item code 201603076 · Approved 2016.05.30 · Insurance code 649404880
Improvement of dyslipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication is used to reduce the risk of various cardiovascular diseases. It decreases the risk of myocardial infarction, stroke, vascular surgery, chronic stable angina, congestive heart failure, and angina, among others. It is especially effective for adults with risk factors such as hypertension, smoking, and family history, as well as for patients with type 2 diabetes. Additionally, it helps treat hyperlipidemia by lowering total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels, while increasing HDL cholesterol. It is also used as an adjunct therapy in the treatment of pediatric patients aged 10 to 17 years with familial hypercholesterolemia. This drug is used to reduce the risk of cardiovascular disease and improve hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, regardless of food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.
Ages 10 ~ 17 years: The recommended initial dose is 10 mg of this medicine daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted at intervals of 4 weeks or longer.
This medication should be discontinued immediately if muscle-related abnormalities occur. Especially if muscle pain, muscle weakness, or muscle cramps occur along with a significant increase in creatine kinase levels, medical attention should be sought. This drug should not be used in patients with specific liver diseases or in those with severely impaired liver function. If liver function test results are significantly abnormal, the medication should be discontinued. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication, as it may be harmful to the fetus or nursing infant. This medication should not be administered to children, especially those under 10 years of age, as safety and efficacy have not been established. Care should be taken when using this medication in patients with certain conditions such as liver disease, renal impairment, hypothyroidism, or alcoholism, and regular monitoring should be conducted to assess their status. There may be interactions with other medications, so if the patient is currently taking any other medications, it is essential to inform the physician or pharmacist. Caution is especially needed when combining with certain antibiotics, antifungals, HIV treatments, and other lipid-lowering agents. During treatment with this medication, if symptoms such as liver function abnormalities, muscle pain, fatigue, or fever occur, the physician should be consulted immediately, and blood tests may be necessary to monitor liver and muscle status. This medication poses a higher risk of myopathy in alcohol abusers or the elderly, so these patients should be observed more closely. Appropriate contraceptive measures should be used during treatment, and if pregnancy is confirmed, the medication should be discontinued immediately and the healthcare provider should be consulted. When storing this medication, keep it out of reach of children, and it should be stored in the original container; it is safest not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. The storage temperature should maintain room temperature between 1 to 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.